Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot clinical study to evaluate sodium phenylbutyrate (Pheburane)
2017-001550-34Phase 2Terminated
- Sponsor
- Fondazione Telethon
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sodium phenylbutyrate in Congenital Metabolic Diseases, sponsored by Fondazione Telethon. Primary endpoint: Reduction of blood lactate. Started Oct 2018; status: terminated.
02
Drugs
sodium phenylbutyrate
03
Conditions
Congenital Metabolic Diseases
Beyond the preview
Go deeper on 2017-001550-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001550-34.